cerium has been researched along with Neoplasm Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aplak, E; Brenneisen, P; Haasler, L; Reichert, AS; Stahl, W; Steckel, B; Stucki, D; von Montfort, C | 1 |
| Dong, H; Jie, MM; Li, JM; Tang, B; Wang, SM; Xiao, YF; Yang, SM; Yang, XC; Yong, X | 1 |
| Giri, S; Graham, RP; Karakoti, A; Maguire, JL; Rattan, R; Reilly, CM; Seal, S; Shridhar, V | 1 |
3 other study(ies) available for cerium and Neoplasm Metastasis
| Article | Year |
|---|---|
CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction.
Topics: Antioxidants; Catalase; Cell Line, Tumor; Cell Proliferation; Cerium; Cytotoxins; Humans; Melanoma; Mitochondria; Nanoparticles; Neoplasm Metastasis; Sulfhydryl Compounds | 2020 |
Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cerium; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nanoparticles; Neoplasm Metastasis; RNA Helicases; Stomach Neoplasms | 2016 |
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cerium; Disease Models, Animal; Endothelial Cells; Female; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Reactive Oxygen Species; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factors | 2013 |